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Abstract
Background: Intestinal parasitic infections (IPI) are a major public health concern in HIV/AIDS patients particularly in
resource-limited settings of Sub-Saharan Africa. Studies investigating the relationship between intestinal parasitic
infections and CD4+ T cell counts and diarrhea in HIV/AIDS patients with or without antiretroviral therapy in the
region are not readily available hence the need to perform this study.
Methods: In a comparative cross-sectional study involving 52 pre-ART and 248 on-ART HIV patients. Stool samples
were collected and analysed for intestinal parasites by wet and iodine mounts, Kato-Katz, formol ether, modified
field staining, and modified Ziehl-Neelsen staining techniques. Blood samples were collected and analysed for
CD4+ T cell counts by flow cytometry. A pre-tested semi-structured questionnaire was used to collect data on
socio-demographic and clinical presentation. Data were analysed using STATA version 12.1. Statistical tests performed
included the Pearson Chi-square, logistic regression and student’s t-test. P < 0.05 was considered to be statistically
significant.
Results: The prevalence of intestinal parasitic infections in pre-ART and on-ART was 84.6 % and 82.3 % respectively
with no significant difference observed with respect to age (p = 0.06), and gender (p = 0.736). All the opportunistic
parasites including Cryptosporidium parvum, Cyclospora cayetanensis, Isospora belli and Microsporidium spp. were isolated
from both groups, with only Microsporidium spp. significantly associated with CD4+ T cell counts below 200 cells/μl in
pre-ART (p = 0.006) while Cryptosporidium parvum, Microsporidium spp. and Isospora belli were associated with counts
below 200 cells/μl in on-ART. Cryptosporidium parvum was significantly associated with diarrhea in pre-ART (p = 0.025)
meanwhile it was significantly associated with diarrhea in on-ART (p = 0.057). The risk of diarrhea was highest in
patients with CD4+ T cell counts below 200 cells/μl (COR = 10.21, p = 0.000) for both pre- and on-ART treatment.
Conclusion: A very high prevalence of intestinal parasitic infections was observed, which did not differ with respect to
ART status. All known opportunistic parasites were isolated in both pre-ART and on-ART patients. Low CD4+ T cell
count may appear to be a factor for intestinal parasitic infections and development of diarrhea. Regular screening and
treatment of intestinal parasitic infections is very vital in improving the overall quality of care of HIV/AIDS patients.
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Background
The neglected intestinal parasitic infections (IPI) which
are caused by either helminthes or protozoa or both are
among the most prevalent parasitic infections responsible
for significant morbidity particularly in resource limited
settings of developing countries. The incidence of IPI is
approximately 50 % in developed countries whereas it
reaches up to 95 % in developing countries, with Sub-
Saharan Africa having the highest burden [1–3]. The Sub-
Saharan African region also has the highest burden of
Human Immunodeficiency Virus (HIV) with an estimated
23.5 million cases [4]. With the overlapping distribution
of these infections, concomitant infection between HIV
and one or more intestinal parasites are therefore com-
mon. Although helminthes have co-existed with humans
for a long time and have probably adapted for long-term
survival in the human host causing relatively minor path-
ology, HIV is relatively a newcomer that destroys the im-
mune defense of the host, making it vulnerable to other
pathogens [5].
Factors prompting transmission of IPI and HIV are most
common in the developing countries [6]. In Cameroon
like most developing countries in Sub-Saharan Africa,
intestinal parasites are widely distributed partly due to
the low level of environmental and personal hygiene,
faecal contamination of food and drinking water and
poor housing. An estimated 80 % of Acquired Immune
Deficiency Syndrome (AIDS) patients die of AIDS-related
opportunistic infections rather than from the HIV virus
itself [7, 8]. Opportunistic parasites such as Cryptospor-
idium parvum, Cyclospora cayetanensis, Isospora belli,
and Microsporidia spp. are a common feature in HIV/
AIDS persons especially when the CD4+ T cell counts
fall below 200 cells/μl [7–9].
Studies investigating the association between intestinal
parasites and the immune status of HIV patients have
reported conflicting outcomes. Some studies have reported
a higher prevalence of IPI in patients with CD4+ T cell
counts below 200 cells/μl [10, 11]. Other studies have re-
ported an increased risk of helminthes infection in HIV pa-
tients with higher CD4+ T cell count [12, 13]. Meanwhile
others have failed to observe any significant association
[14–17]. Just a few studies published currently have ac-
tually investigated the effect of antiretroviral therapy in
individuals with concomitant infection with intestinal
parasites and HIV, with some of these studies suggest-
ing that antiretroviral therapy may have a role to play in
the risk and severity of intestinal parasites in HIV/AIDS
patients [18, 19].
Various microorganisms have been isolated from HIV-
infected patients with chronic diarrhea either singly or
in combinations [20]. Diarrhea remains a leading cause
of morbidity and mortality in the developing world and
accounts for over 50 million deaths globally [21] and has
been ranked third among diseases responsible for human
mortality in the world [22]. It occurs in 30 to 60 percent
of North American and European patients and almost
90 % of AIDS patients in developing countries [23] in-
cluding Cameroon.
In the present study, we determined the relationship
between IPI and the CD4+ T cell count as well as the
diarrheic status of HIV infected persons who were on




Participants were enrolled in the HIV treatment centers
of the Buea and Limbe Regional Hospitals located in
Buea and Limbe of Cameroon. Buea (4°10′N 9°14′E)
has a population of about 200,000 inhabitants and Limbe
(4°01′N 9°13′E) has a population of about 151,258 inhabi-
tants are the two major urban centers in the Fako division
of the South West Region of Cameroon. These two hospi-
tals are the only HIV treatment centers in Fako Division
serving the entire population. Limbe is the head quarter of
the Cameroon Development Corporation (CDC), the sec-
ond largest employer in Cameroon after the government
and also a major tourist sites with features such as the
beach, botanical garden and the zoo. The Mountain in
Buea is also a major tourist site and Buea is home to the
first Anglo-Saxon state university; the University of Buea.
Almost all ethnic groups in Cameroon are represented in
these towns attracted by the business friendly environ-
ment and job opportunities. The 8 % HIV of the South
West Region is one of the highest in the country [24].
Figure 1 [25] shows the two study communities in the
South West Region of Cameroon.
Study design and Setting
This was a hospital-based cross-sectional study in which
participants of the Buea and Limbe Regional Hospitals
HIV treatment centers were enrolled between April and
July 2014.
Sample size calculation
The sample size was determined using the formula for
sample size calculation [26].
n ¼ Zð Þ
2p 1−pð Þ
e2
Where n = sample size,
Z ¼ constant ¼ 1:96
p = prevalence of intestinal parasites among HIV posi-
tive patients = 27.9 % [27].
e = precision of the event of interest = 0.05
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n ¼ 1:96ð Þ
2 0:279ð Þ 0:721ð Þ
0:052
¼ 309 participants
A total of 313 patients were contacted but only 300
were consecutively recruited during the study period.
Sampling technique
A time limited sampling technique was used, where pa-
tients were consecutively recruited into the study. Partic-
ipants were enrolled into the study provided they gave
their consent and met the inclusion criteria.
Study population
HIV patients attending the HIV treatment centers of the
Regional Hospitals in Buea and Limbe were approached
to take part in the study. The study population was made
up of HIV patients who had not yet commence treatment
(pre-ART) and HIV patients who were already receiving
treatment (on-ART). To be included in the study, patients
irrespective of their ages and gender were eligible to
participate. Individuals that were on any anti-parasitic
medication prior to data collection were excluded from
the study.
Data collection and processing
Administration of Questionnaire
A pretested semi-structured questionnaire was adminis-
tered in order to collect socio-demographic characteris-
tics and clinical information from consented participants
who agreed to participate in the study.
Specimen collection
Stool samples were collected into wide open-necked, ster-
ile containers which were provided to the participants.
The participants were instructed on how to collect stool
samples at the point of care. These samples were analysed
within one hour of collection for ova, cyst and parasites.
Samples were stored in 10 % formol ether for 24 h and
later stained for intestinal oocyts. After the provision of
stool samples, about 4 ml of peripheral blood was col-
lected into EDTA test tubes. These samples were immedi-
ately used for the analysis of the CD4+ T cell counts.
Parasitological analysis of stool specimen
The presence of diarrhea was defined as a history of
frequent passage (3 times or more) of watery stool in a
24 h period and confirmed by macroscopic examination
of stool sample. Stool samples were analysed using sa-
line and iodine mount, Kato-katz [28] and formol ether
concentration techniques [29]. Smears prepared from
the formol ether concentration techniques were stained
using the Modified field staining technique for the detec-
tion of spores of Microsporidium species [30], and the
Modified Ziehl-Neelsen staining technique was used for
the detection of oocysts of Cryptosporidium species,
Isospora belli, and Cyclospora cayetanensis [31].
Analysis of CD4+ T cell count
CD4+ T cell counts were determined using the BD
FACSCount™ System (BD Biosciences, USA) as per the
manufacturer’s instructions. Briefly, CD4 reagent tubes
were labeled and vortexed upside down for 5 seconds
and upright for 5 seconds. The reagent tubes were
opened with the coring station. EDTA tubes containing
blood were inverted 5 to 10 times to adequately mix the
blood. 50 μl of whole blood was pipetted into the reagent
tubes. Each tube was caped and vortexed upright for
5 seconds. The tubes were incubated for 60 to 120 min
at room temperature in the dark. The tubes were un-
capped and 50 μl of fixative solution were pipetted into
Fig. 1 Map of Africa showing Cameroon and the two study sites. Source: Orock FT and Lambi CM, 2014 [25]. Permission was granted by the
copy-right holders to reproduce this figure
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the tubes. The tubes were recapped and vortexed for
5 seconds.
The samples were vortexed upright for 5 seconds before
they were analysed on the FACS Count instrument [32].
Ethical considerations
Ethical clearance was obtained from the Institutional
Review Board of the Faculty of Health Sciences of the
University of Buea (Reference Number: 2014-02-0214).
Administrative authorization was obtained from the South
West Regional Delegation of the Ministry of Public Health
and the District Health Services. The purpose of the study
and the role of the participants were well explained ver-
bally and in the consent form to the participants and par-
ticipation could only take place after the participant had
read and signed the informed consent form voluntarily.
Statistical analysis
Data were analysed using STATA version 12.1. Statistical
significant differences in proportions were evaluated by
Pearson’s Chi-square test. The student’s t-test was used
to compare groups mean. Bivariate analysis was used to
assess the effects of intestinal parasites on the CD4+ T
cell counts and diarrheic state of the study participants.
Where appropriate the Fisher exact test was used to
determine p-values. Statistical significance was set at
p < 0.05.
Limitations to the study
Molecular identification techniques for parasitic species
were not done due to sparsely equipped laboratories.
Also Only single stool samples were collected from each
participant. However, to overcome these limitations each
stool sample was analyzed more than once using differ-
ent techniques in order not to miss out parasites present
in low quantity.
Results
Socio-demographic characteristics of the respondents
At the end of the study, 300 participants were success-
fully enrolled. Among them were 64(21.3 %) males and
236(78.6 %) females. The ages of the participants ranged
between 21–65 years with mean (±SD) age, 40(±10) years.
Fifty two (17.3 %) of the 300 participants were pre-
ART meanwhile 248 (82.7 %) were on-ART. The mean
age of on-ART patients was 42.6(±9.9) years while that
of pre-ART patients was 40.2(±10.2) years. No significant
difference was observed in the mean ages between the two
groups (p = 0.06). Among the 52 pre-ART HIV patients,
were 40 (76.9 %) females and 12 (23.1 %) males while
among the 248 on-ART HIV patients were 196 (79.1 %)
females and 52 (20.9 %) males. No significant difference
was observed with respect to gender in the two groups
(p = 0.736).
Prevalence of intestinal parasite in pre-ART and on-ART
HIV/AIDS patients
Intestinal parasites were isolated from 248 (82.6 %) of
the 300 participants. Intestinal protozoa were more
prevalent than intestinal helminthes [223 (74.3 %) vs. 34
(11.3 %)]. IPI was more prevalent in females [199
(84.3 %)] than in males [49 (76.5 %)] (p = 0.14). Overall,
the prevalence of IPI was higher in HIV patients above
60 years [13 (92.9 %)] (Table 1). Among pre-ART HIV
patients, the prevalence of IPI was highest in the age
group 31–40 meanwhile among on-ART HIV patients
the prevalence was highest in patients above 60 years.
However, no statistical significance was observed between
prevalence of IPI and age group (p = 0.47).
The prevalence of IPI was higher in pre-ART HIV pa-
tients [44/52 (84.6 %)] than in on-ART HIV patients
[204/248 (82.3 %)]. However no significant association
was observed between prevalence of intestinal parasite
and ART (p = 0.900). Among pre-ART patients, IPI was
higher among males [36 (90 %)] than in females [10
(83.3 %)] meanwhile among on-ART HIV patients, IPI
was higher among females [163 (83.2 %)] than in males
[39 (75 %)]. No significant association was observed in the
prevalence of IPI and gender in both pre-ART (p = 0.526)
and on-ART (p = 0.178) HIV patients.
The commonest intestinal parasite was Cryptosporidium
parvum [132 (44 %)], while the least prevalent was Stron-
gyloides stercoralis [2(0.7 %)]. Cryptosporidium parvum
was also the most prevalent intestinal parasite in both
pre-ART and on-ART HIV patients (Table 2). Species-
specific analysis revealed that no particular intestinal
parasite was statistically significantly associated with
ART status (Table 2).
Association of intestinal parasite with CD4+ T cell count
among pre-ART and on-ART HIV/AIDS patients
The prevalence of IPI was highest [71 (93.4 %)] in patients
with CD4+ T cell count below 200 cells/μl, (Table 3). A
highly significant association was observed between preva-
lence of IPI and low CD4+ T cell count (p = 0.000). Among
pre-ART patients, the prevalence of IPI was highest in
individuals with CD4+ T cell count below 200 cells/μl
Table 1 Distribution of IPI with age in the study population








21 – 30 47 11(84.6) 27(77.1) 38(80.9)
31 – 40 118 23(92.0) 76(81.7) 99(83.9)
41 – 50 89 10(76.9) 60(77.9) 70(78.7)
51 – 60 32 0(0.0) 28(90.3) 28(87.5)
>61 14 0(0.0) 13(92.9) 13(92.9)
Total 300 44 204 248
The number of pathogens exceeds the number of patients as multiple
parasites were identified in some patients
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(p = 0.004) meanwhile among on-ART HIV patients, the
prevalence was highest in patients with CD4+ T cell count
between 200–499 cells/μl (p = 0.000).
Species-specific analysis revealed that Cryptosporidium
parvum, Microsporidium spp., Isospora belli and hook-
worm were the parasite species most significantly asso-
ciated with low CD4+ T cell count (p = 0.000, p = 0.000,
p = 0.003 and p = 0.034 respectively) (Table 3). Among
pre-ART HIV patients, only Microsporidium spp. was
significantly associated (p = 0.006) with low CD4+ T cell
count meanwhile C. parvum, B. hominis, Microsporidium
spp. and I. belli were significantly associated with low
CD4+ T cell count among on-ART HIV patients (p = 0.000,
p = 0.039, p = 0.000 and p = 0.003 respectively) (Table 4).
Association of intestinal parasite with diarrhea among
pre-ART and on-ART HIV/AIDS patients
A total of, 103 (87.3 %) of the 118 participants who pre-
sented with diarrhea had intestinal parasites while 145
(79.7 %) of the 182 participants without diarrhea had in-
testinal parasites (Table 5). Overall, no significant associ-
ation was observed between the presence of IPI and
diarrhea (p = 0.08). No significant association was also
observed between the prevalence of IPI and diarrhea
among pre-ART (p = 0.083) and on-ART (p = 0.3) HIV
patients.
Species-specific analysis indicated that diarrhea was
observed to be associated with infection with Cryptosporid-
ium parvum, Cyclospora cayetanensis, and Microsporidium
spp (p = 0.008, p = 0.028, p = 0.011 respectively) (Table 6).
Among pre-ART HIV patients, Cryptosporidium parvum
was observed to be significantly associated with diarrhea
(p = 0.025) while no intestinal parasite was significantly
associated with diarrhea among pre-ART HIV patients
(Table 6).
A highly significant association was observed between
CD4+ T cell count and diarrhea (P = 0.000). The risk of
diarrhea was observed to increase with decreasing CD4+
T cell count independent of parasitic infection and with
HIV patients with counts below 200 cells/μl having ex-
cess risk compared to those with CD4+ T cell count
above 500 cells/μl (COR = 10.21, p = 0.000).
Discussion
Intestinal parasitic infections (IPI) are a major public
health concern in HIV/AIDS patients in developing coun-
tries particularly in Sub-Saharan Africa where the highest
burden of HIV is also recorded [4]. Antiretroviral therapy
(ART) which is now widely available in the region has
brought about a significant improvement in the lives of
HIV-infected persons. Studies comparing the prevalence
and associated factors of IPI among HIV/AIDS patients
on-ART compared to pre-ART patients particularly in
Sub-Saharan Africa are not readily available hence the
need to investigate the prevalence of intestinal parasites in
relation to the CD4+ T cell count and diarrheic status in
HIV/AIDS patients before and during administration of
ART.
In this study, there was no statistically significant differ-
ence (p = 0.128) between the prevalence (88 % vs. 81.6 %)
of IPI in pre-ART compared to on-ART patients respect-
ively which was in contrast to the study by Missaye and
Table 2 Species-specific prevalence of intestinal parasites






On-ART No (%) Pre-ART No (%)
Protozoa
C. parvum 132(44.0) 109 (53.4) 23 (52.3) 0.971
B. hominis 75(25.0) 59 (28.9) 16 (36.4) 0.292
Microsporidiumsp 64(21.3) 50 (24.5) 14 (31.8) 0.280
E. hystolytica 22(7.3) 18 (8.8) 4 (9.0) 0.913
I.belli 13(14.3) 12 (5.9) 1 (2.3) 0.349
C.cayetanensis 11(3.6) 9 (4.4) 2 (4.6) 1.000*
G.lamblia 10(3.3) 8 (3.9) 2 (4.6) 0.686*
Helminths
A.lumbricoides 13(4.3) 12 (5.9) 1 (2.3) 0.349
Hookworm 8(2.7) 8 (3.9) 0 (0.0) -
T.trichuria 7(2.3) 6 (2.9) 1 (2.3) 0.830*
H. nana 4(1.3) 4 (2.0) 0 (0.0) -
S. stercoralis 2(0.7) 2 (1.0) 0 (0.0) -
Total 248 (82.6) 204 (82.3) 44 (84.6)
*P value from Fisher’s exact test
Table 3 Prevalence of intestinal parasitic infection with respect to CD4+ T cell count
CD4+ T cell count Pre-ART On-ART Overall
Present No (%) Absent No (%) Present No (%) Absent No (%) Present No (%) Absent No (%)
<200cells/μl 17(100) 0(0) 54(91.5) 5(8.5) 71 (93.4) 5 (6.5)
200 – 499cells/μl 20(95.2) 1(4.8) 93(92.1) 8(7.9) 113 (92.6) 9 (7.3)
≥500cells/μl 9(64.3) 5(35.7) 55(62.5) 33(37.5) 64 (62.3) 38 (37.6)
Total 46 6 202 46 248 52
χ2, P-value χ2 = 11.179, p = 0.004 χ2 = 34.137, p = 0.000 χ2 = 42.825, p = 0.000
χ2 = Chi square values for the association between CD4+ T cell counts and Antiretroviral therapy
Nsagha et al. BMC Infectious Diseases  (2016) 16:9 Page 5 of 10
Table 4 Prevalence of intestinal parasite among HIV/AIDS patients in relation to their CD4+ T cell Counts among pre-ART and on-ART HIV patients
Parasite species No (%) Pre-ART On-ART Overall
CD4+ T cell counts CD4+ T cell counts CD4+ T cell counts
<200 No(%) 200-499 No (%) >500 No(%) P - value <200 No(%) 200-499 No(%) >500(%) P- value <200 No(%) 200-499 No(%) >500 No(%) P - value
C. parvum 132(44) 8(47.1) 11(52.4) 3(21.4) 0.171 36(61) 53(52.5) 21(23.9) 0.000 44(57.8) 65(52.8) 23(22.7) 0.000
B. hominis 75(25) 6(35.3) 5(23.8) 3(21.4) 0.63 13(22) 33(32.7) 15(17.1) 0.039 19(25.0) 38(30.8) 18(17.8) 0.080
Microsporidium spp. 64(21.3) 10(58.8) 4(19.1) 0(0) 0.006 23(39) 23(22.8) 4(4.6) 0.000 33(43.4) 27(21.9) 4(3.9) 0.000
E. hystolytica 22(7.3) 0(0) 4(19.1) 2(14.3) 0.175 1(1.7) 7(6.9) 8(9.1) 0.195 1(1.3) 12(9.7) 9(8.9) 0.065
Isospora belli 13(4.3) 1(5.9) 0(0) 0(0) 0.43 7(11.9) 5(5) 0(0) 0.003 8(10.5) 5(4.1) 0(0.0) 0.003
C. cayetanensis 11(3.6) 0(0) 2(9.5) 0(0) 0.29 4(6.8) 4(4) 1(1.1) 0.15 4(5.2) 6(4.8) 1(0.9) 0.211
G. lambia 10(3.3) 0(0) 1(4.8) 1(7.1) 0.731* 0(0) 4(4) 4(4.6) 0.307* 0(0.0) 5(4.1) 5(4.9) 0.162
Lumbricoides 13(4.3) 1(5.9) 0(0) 1(7.1) 0.509* 2(3.4) 3(3) 6(6.8) 0.421* 3(3.9) 3(2.4) 7(6.9) 0.255
Hookworm 8(2.7) 0(0) 0(0) 0(0) - 0(0) 2(2) 6(6.8) 0.072* 0(0.0) 2(1.6) 6(5.9) 0.034*
T. trichuria 7(2.3) 0(0) 1(4.8) 1(7.1) 0.731* 1(1.7) 1(1) 3(3.4) 0.543* 1(1.3) 2(1.6) 4(3.9) 0.409*
H. nana 4(1.3) 0(0) 0(0) 1(7.1) 0.269* 0(0) 3(3) 0(0) 0.183* 0(0.0) 3(2.4) 1(0.9) 0.323*
S. stercoralis 2(0.7) 0(0) 0(0) 0(0) - 2(3.4) 0(0) 0(0) 0.056* 2(2.6) 0(0.0) 0(0.0) -
Total 361 26 28 12 89 138 68 115 168 78
The number of pathogens exceeds the number of patients as multiple parasites were identified in some patients














colleagues [18] in Ethiopia. A high prevalence of intestinal
protozoa than intestinal helminthes (74.3 % vs. 11.3 %)
was is in line with studies performed elsewhere [10, 18,
33, 34]. Cryptosporidium parvum was highly prevalent
(44 %) in both pre-ART and on-ART HIV patients, which
was in contrast to studies that have reported Entamoeba
histolytica/dispar as the most prevalent intestinal parasite
in HIV/AIDS patients [10, 11, 18], as well as those report-
ing Blastocystis hominis as the most prevalent intestinal
parasite [33]. The prevalence of Cryptosporidium parvum
observed in this study is very high compare to studies
which have reported prevalence in the range of 2.2 to
15.8 % [1, 33, 35–38]. On the contrary this high preva-
lence of Cryptosporidium was in line with the study
performed by Missaye and collleagues [18]. Cryptospor-
idium parvum, Cyclospora cayetanensis, Isospora belli
and Microsporidia are often recognized as opportunis-
tic parasites in HIV/AIDS patients because they tend to
be present when the CD4+ T cell counts are below 200
cells/μl [9]. Parasite species was observed to be signifi-
cantly associated with ART status which is contrary to
the study by Missaye and colleagues [18] in which Ena-
tamoeba histolytica was observed to be significantly
higher in pre-ART patients.
In this study, IPI prevalence was significantly higher
in patients with CD4+ T cell count below 200 cells/μl
(p = 0.000) which is in line with studies published else-
where [10, 11, 18]. Among the parasites isolated, only
Cryptosporidium parvum, Microsporidium spp., Isospora
belli and hookworm were observed to be significantly as-
sociated with CD4+ T cell count. These parasites with the
exception of hookworm take advantage of the low CD4+
T thus causing infection in these patients. Cellular im-
munity is the major defense against intestinal parasitic in-
fections. Therefore, the reduction in CD4+ T cell count by
the HIV virus predisposes HIV-infected patients to these
opportunistic intestinal parasitic infections. Other studies
have also reported a significant association of CD4+ T cell
with increase Cryptosporidium parvum [10, 18], and
Isospora belli [10]. In this study, only Microsporidium
spp. was significantly associated with low CD4+ T cell
count among pre-ART HIV patients meanwhile C. par-
vum, B. hominis, Microsporidium spp. and I. belli were all
significantly associated with low CD4+ T cell count in the
on-ART group. This is contrary to the study by Missaye
and colleagues [18] in which Cryptosporidium parvum
was the only species observed to be significantly associ-
ated with CD4+ T cell count below 200 cells/μl in pre-
ART patients.
Overall, no significant association was observed between
IPI and diarrhea which is very much in line with the study
by Assefa and colleagues [10] but contrary to the study by
Teklemariam and colleagues [11] where a significant
association was observed. The opportunistic parasites;
Crytosporidium parvum, Blastocystis hominis and Micro-
sporidium spp. were significantly associated with diarrhea.
These parasites being intracellular disrupt epithelial cells
resulting to fluid and electrolyte loss. Patients with CD4+
T cell count below 200 cells/μl were more likely to have
diarrhea (COR = 10.21, p = 0.000) which is in line with
studies performed elsewhere [10, 11]. This confirms that
the weakened immunity predisposes HIV patients to in-
fection with opportunistic parasites which worsen the
prognosis hence the onset of diarrhea. Among pre-ART
HIV patients, C. parvum was observed to be significantly
associated with diarrhea meanwhile no intestinal parasite
was observed to be associated with diarrhea in the on-ART
group. This suggests that ART plays a role in preventing
the development of diarrhea as a result of IPI in HIV/AIDS
patients, which could be beneficial for a better health of
these patients.
Conclusion
The prevalence of IPI was significantly higher in HIV/
AIDS patients with CD4+ T cell count below 200 cells/μl.
Microsporidium spp. was significantly associated with low
CD4+ T cell counts in pre-ART. Only Cryptosporidium
parvum was significantly associated with diarrhea in pre-
ART HIV patients with none in the on-ART group. This
study clearly shows that low CD4+ T cell count appeared
to be a risk factor for infection with intestinal parasites
and the development of diarrhea in HIV/AIDS irrespect-
ive of the ART status. Regular screening and treatment for
intestinal parasites and the strengthening of adherence to
ART to increase the CD4+ T cell counts is of prime
Table 5 The occurrence of diarrhea among the study participants stratified by ART status and IPI
Diarrhea
status
n Overall Pre-ART On-ART
Parasites present No (%) Parasites absent
No (%)
Parasites present No (%) Parasites absent
No (%)
Parasites present No (%) Parasites absent
No (%)
Present 118 103(87.3) 15(12.7) 25 (96.2) 1(3.8) 78(84.8) 14(15.2)
Absent 182 145(79.7) 37(20.3) 21(80.8) 5(19.2) 124(79.5) 32(20.5)
Total 300 248(82.6) 52(17.3) 46(88.5) 6(11.5) 204(81.6) 46(18.4)
χ2, P-value χ2 = 2.88, p = 0.08 χ2 = 3.015, p = 0.083 χ2 = 1.074, p = 0.300
χ2 = Chi square values for the association between diarrhea, parasites with Antiretroviral therapy
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Table 6 Association between intestinal parasite and Diarrhea














C. parvum 132 15(57.7) 7(26.9) 0.025 48(52.2) 62(39.7) 0.057 63(53.4) 69(37.9) 0.008
B. hominis 75 7(26.9) 7(26.9) 1.000 15(16.3) 46(29.5) 0.020 22(18.6) 53(29.1) 0.041
Microsporidium spp. 64 9(34.6) 5(19.2) 0.211 25(27.2) 25(16) 0.035 34(28.8) 30(16.5) 0.011
E. hystolytica 22 1(3.9) 5(23.8) 0.083 3(3.2) 13(8.3) 0.116 4(3.4) 18(9.9) 0.035
I. Belli 13 1(3.9) 0(0) 0.313 7(7.6) 5(3.2) 0.118 8(6.8) 5(2.8) 0.094
C. cayetanensis 11 2(7.7) 0(0) 0.490* 6(6.5) 3(1.9) 0.081* 8(6.8) 3(1.7) 0.028*
A. lumbricoides 13 1(4) 1(4) 1.000 1(1.1) 10(6.4) 0.058 2(1.7) 11(6) 0.071
G. lambia 10 0(0) 2(7.7) 0.490* 4(4.4) 4(2.6) 0.474* 4(3.4) 6(3.4) 1.000*
Hookworm 8 0(0) 0(0) 1.000* 0(0) 8(5.1) 0.028* 0(0) 8(4.6) 0.024*
T. trichuria 7 0(0) 2(7.7) 0.490* 1(1.1) 4(2.6) 0.654* 1(0.9) 6(3.4) 0.252*
H. nana 4 0(0) 1(3,9) 1.000* 3(3.2) 0(0) 0.050* 3(2.5) 1(0.6) 0.304*
S. stercoralis 2 0(0) 0(0) 1.000* 2(2.2) 0(0) 0.137* 2(1.7) 0(0) 0.154*
Total 361 36 30 115 180 151 210
The number of pathogens exceeds the number of patients as multiple parasites were identified in some patients














importance to improve the overall wellbeing of HIV/AIDS
patients in this study area.
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